Abstract
BackgroundWhole-genome sequencing (WGS) and whole-exome sequencing (WES) technologies are increasingly used to identify disease-contributing mutations in human genomic studies. It can be a significant challenge to process such data, especially...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have